Delivery Order SPE2DB20D9127-SPE2DB24FPPH8
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of ISOSULFAN BLUE 1% VIAL 5ML medical supplies, with a ceiling value of $7,430.84 and a period of performance through April 16, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, a delivery order valued at $29,723.36 for Isosulfan Blue 1% vials (5mL) on August 8, 2025. The contract utilizes a firm fixed-price delivery order structure with an ultimate completion date of August 11, 2025, and carries no set-aside designation. This award falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $29,723.36 on August 18, 2025, for the supply of Isosulfan Blue 1% in 5ml vials. The award, issued by the Defense Logistics Agency under its Medical Supply Chain program, represents a delivery order against DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $5,073.48 contract is for the delivery of VISIONBLUE 0.06% SYRINGE 0.5ML. The order has a period of performance through June 30, 2025. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,556.52, is for the delivery of a pharmaceutical product, specifically VisionBlue 0.06% Syringe 0.5ML. The contract has a completion date of September 8, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group Inc. holds a larger...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,013.70 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of 0.5 mL syringes containing 0.025% Tissue Blue solution. This order is issued against DMS Pharmaceutical's indefinite delivery contract SPE2DB valued at up to $4,999,999 through 2025, which enables DLA to procure a broad range of pharmaceutical products for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,382.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on August 19, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 10, 2025, covers the supply of VisionBlue 0.06% syringes in 0.5ml units. The award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its merits within the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,227.90 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of VisionBlue 0.06% syringes in 0.5ML units. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge facility and will...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,654.44 to DMS Pharmaceutical Group Inc. for TISSUEBLUE 0.025% syringe in 0.5mL quantities. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. The award was issued on September 17, 2025, with an ultimate completion date of October 8, 2025. No set-aside designation was used for this procurement. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,136.10 by the Defense Logistics Agency (DLA) on August 25, 2025. The contract calls for delivery of TissueBlue 0.025% Syringe 0.5ML, a pharmaceutical product to be delivered to Park Ridge, Illinois, with an ultimate completion date of September 16, 2025. This delivery order was issued without a set-aside designation,...
- SPE2DB20D9127Indefinite Delivery Contract
- SPE2DB20D9127-SPE2DB24FPPH8Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,985.30, is for the delivery of 4563043017 - Isosulfan Blue 1% Vial 5ML, with a period of performance through December 5, 2023. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the medical supply needs of military health facilities worldwide. The contract award is not associated with any specific set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/4/23 |